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Gammaherpesvirus infection modulates the temporal
and spatial expression of SCGB1A1 (CCSP) and BPIFA1
(SPLUNC1) in the respiratory tract
Gail H Leeming1,2, Anja Kipar1,2,3, David J Hughes1,9, Lynne Bingle4, Elaine Bennett1, Nathifa A Moyo1,
Ralph A Tripp5, Alison L Bigley6, Colin D Bingle7, Jeffery T Sample8 and James P Stewart1
Murine g-herpesvirus 68 (MHV-68) infection of Mus musculus-derived strains of mice is an established model of
g-herpesvirus infection. We have previously developed an alternative system using a natural host, the wood mouse
(Apodemus sylvaticus), and shown that the MHV-68 M3 chemokine-binding protein contributes significantly to MHV-68
pathogenesis. Here we demonstrate in A. sylvaticus using high-density micro-arrays that M3 influences the expression of
genes involved in the host response including Scgb1a1 and Bpifa1 that encode potential innate defense proteins secreted
into the respiratory tract. Further analysis of MHV-68-infected animals showed that the levels of both protein and RNA
for SCGB1A1 and BPIFA1 were decreased at day 7 post infection (p.i.) but increased at day 14 p.i. as compared with
M3-deficient and mock-infected animals. The modulation of expression was most pronounced in bronchioles but
was also present in the bronchi and trachea. Double staining using RNA in situ hybridization and immunohistology
demonstrated that much of the BPIFA1 expression occurs in club cells along with SCGB1A1 and that BPIFA1 is stored
within granules in these cells. The increase in SCGB1A1 and BPIFA1 expression at day 14 p.i. was associated with the
differentiation of club cells into mucus-secreting cells. Our data highlight the role of club cells and the potential of
SCGB1A1 and BPIFA1 as innate defense mediators during respiratory virus infection.
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Murine g-herpesvirus 68 (MHV-68, Murid herpesvirus 4
(MuHV-4)) infection of laboratory mice is a tractable
and widely used small-animal model of g-herpesvirus
infection,1–7 specifically for the human pathogens Epstein–
Barr virus and Kaposi’s sarcoma-associated herpesvirus.
Laboratory mice (M. musculus) are not a natural host for
MHV-68.8–11 So, to define host–pathogen interactions in an
authentic system, we have developed infection of wood mice
(A. sylvaticus), which are a natural host of MHV-68, as an
alternative model.12 The host response to MHV-68 in wood
mice differs from that seen in laboratory mice. Intra-nasal
infection of wood mice with MHV-68 leads to productive
replication in lung epithelial cells and in macrophages within
granulomatous infiltrates that peaks at day 7 post infection
(p.i.) and is resolved by day 21 p.i.12 This is followed by a
latent infection of B cells in the spleen and in the lung within
perivascular and peribronchiolar lymphocyte accumulations
that leads to the formation of iBALT. The expansion of
latently infected B cells peaks at day 14 p.i. but MHV-68 then
establishes a latent infection in the spleen and lung that
persists long term.12 The M3 gene of MHV-68 encodes a
viral chemokine-binding protein, known to bind a range
of chemokines in vitro; however, its in vivo function could
not be discerned when using laboratory mice that are a
non-natural host.13,14 Our previous experiments in wood
mice using an MHV-68 mutant deficient in M3 showed that
although M3 is not essential for infection, there is a marked
alteration in the cellular response to the M3 mutant.
Specifically, in wood mice infected with MHV-68 lacking
M3, there is an alteration in the chemokine and cytokine
environment, loss of the B-cell-dominated infiltrate in lungs
at day 7 p.i., absence of iBALT formation at day 14 p.i., and a
significantly reduced latent infection,15 further highlighting
the significance of our wood mouse system.
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The airway epithelium secretes multiple proteins that
function in innate defense. Two highly expressed proteins
that are thought to have this role are secretoglobin, family
1A, member 1 (SCGB1A1; also called uteroglobin, club
(Clara) cell secretory protein or CC10) and BPI fold-con-
taining family A1 (BPIFA1; also called SPLUNC1).16–20
SCGB1A1 is produced by non-ciliated epithelial, ie, club
cells (Clara cells) in the airways.16 The precise role of
SCGB1A1 has not been clearly defined and is likely to be
multifactorial. However, Scgb1a1 / mice show both increa-
sed viral loads and increased pulmonary inflammation
following respiratory syncytial virus infection21 and
increased inflammatory, cytokine, and chemokine responses
following infection with an E1- and E3-deleted adenoviral
vector.22
BPIFA1 is found in the respiratory epithelium and sub-
mucosal glands of the upper airways and in the salivary
glands in mice and humans.17–19,23–25 The interspecies
diversity and rapid evolution of BPIF genes26,27 suggest a
role for the proteins in host defense. BPIFA1 has a surfactant-
like function28 and is involved in the regulation of the
amiloride-sensitive epithelial sodium channel, ENaC.29
Infection with Mycoplasma spp. induces Bpifa1 expression
in murine airways30 and, importantly, BPIFA1 enhances IL-8
production and bacterial clearance.30 Recent data also suggest
that the protein is important in the defense against Klebsiella
pneumoniae infection31 and acts through modulation of
macrophage function.32
As part of a study to identify transcriptional signatures
associated with the MHV-68 M3 protein during infection, we
identified a modulation of Scgb1a1 and Bpifa1 expression.
Here we describe the temporal and spatial changes in the
expression of these two genes and their products during
MHV-68 infection of wood mice.
METHODS
Cell Culture and Virus
Stocks of MHV-68, clone g2.4,33 and previously published,
genetically engineered mutant MHV-68 viruses vM3.stop and
vM3.MR13 were grown and titrated by infection of baby
hamster kidney cells (BHK-21), as previously described.34
vM3.stop contains a stop codon inserted into the M3 locus
so as to disrupt the production of M3 protein. vM3.MR is
a marker-rescue control virus derived from vM3.stop
that expresses M3. BHK-21 cells were maintained in
Glasgow’s Modified Minimal Essential Medium with 10%
newborn calf serum and 10% tryptose-phosphate broth,
2mM L-glutamine, 70 mg/ml penicillin, and 10 mg/ml
streptomycin.
Wood Mice
Animal work was reviewed by the local University of
Liverpool ethics committee and performed under UK Home
Office Project Licence 40/2483 and personal licence 60/6501.
MHV-68-negative, laboratory bred wood mice (Apodemus
sylvaticus) were obtained from the established colony at the
University of Liverpool, housed, and maintained as pre-
viously described.12,15
Virus Infection
Animals were randomly assigned into multiple cohorts, an-
esthetized lightly with halothane, and separate cohorts in-
oculated intra-nasally with either 4 105 PFU of MHV-68 or
recombinants vM3.stop (M3 deficient) or vM3.MR (marker-
rescue control; kind gifts of Samuel Speck, Herbert W. Virgin
IV and Victor van Berkel13) in 40 ml sterile PBS, or were mock
infected with PBS. They were killed on day 7 or 14 p.i. by
cervical dislocation. Lungs and trachea were removed
immediately and samples subjected to RNA purification or
fixed for histology and transmission electron microscopy
(TEM). A sample size of n¼ 3 was used and was determined
using power calculations and previous experience of
experimental infection with these viruses. Separate cohorts
of mice were used for microarray analysis, RNA (quantitative
reverse transcriptase-PCR (qRT-PCR)) analysis, histopatho-
logy (RNA in situ, immunohistology (IH)), and electron
microscopy.
Microarray Analysis
Microarray work was performed by the University of Liver-
pool Centre for Genomic Research (http://www.liv.ac.uk/
genomic-research/). Cohorts of three wood mice were in-
fected with MHV-68 vM3.MR or vM3.stop35 and euthanized
on day 14 p.i. Total cellular RNA was purified from the lungs
using an RNeasy mini kit (Qiagen). We used one lung sample
from each mouse per chip, ie, three biological replicates
for each infection group. RNA quality was assessed using a
2100 bioanalyzer (Agilent Technologies) and 5 mg used for
array hybridization. RNA was reverse transcribed, amplified
in vitro, biotinylated, cRNA fragmented, hybridized to Mouse
Genome 430A V2 arrays, and scanned following Affymetrix
protocols (http://www.affymetrix.com). Image processing
and normalizations were performed using the Affymetrix
MAS 5.0 software before input into GeneSpring (Agilent
Technologies). The derived signal value was globally
normalized and targeted to all probe sets equal to 100
before comparative analysis. Data were normalized per chip
and to the 50th percentile. Signal intensities represent the
abundance of RNA transcripts. Genes (probe sets) showing
greater than twofold change in value and with a Po0.001
with respect to ‘Present’ or ‘Absent’ flags were chosen as
changed genes. Genes whose expression was regulated more
than twofold are described in Table 1.
Cloning and Sequencing of Wood Mouse cDNAs
Total RNA was purified from lung tissue of uninfected A.
sylvaticus using the RNeasy Mini Kit (Qiagen) and DNA
contamination removed by treating RNA with amplification
grade DNase I (Life Technologies) according to the manu-
facturers’ recommendations. Reverse transcription was
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Table 1 Genes whose expression was modulated in the lungs of wood mice infected with vM3.MR compared with those infected
with vM3.stop
Symbol Description Tissue/cell specificity Biological processa Ratiob
Upregulated in vM3.MR-infected wood mice
Immune/inflammatory response
Igha Immunoglobulin heavy constant a Lymph node, intestine Mucosal immune response 2.6
Ighg1 Immunoglobulin heavy constant gamma 1 Lymph node Humoral immune response mediated by circulating Ig 4.5
Ighg2b Immunoglobulin heavy constant gamma 2B Lymph node Humoral immune response mediated by circulating Ig 2.4
Ighm Immunoglobulin heavy constant mu Lymph node Humoral immune response mediated by circulating Ig 2.8
Ighm Immunoglobulin heavy constant mu Lymph node Humoral immune response mediated by circulating Ig 3
Ighv1–72 Immunoglobulin heavy variable 1–72 Lymph node, small intestine Humoral immune response mediated by circulating Ig 2.7
Igk-V8 Immunoglobulin k chain B cells, lymph node Humoral immune response mediated by circulating Ig 5.7
Igkv8–30 Immunoglobulin k chain variable 8–30 B cells, lymph node Humoral immune response mediated by circulating Ig 3.4
Igkc Immunoglobulin k constant B cells, lymph node B-cell differentiation 2.4
Oas2 2’-5’ Oligoadenylate synthetase 2 Macrophage Immune response/Rnase L induction 2
C1qb Complement component 1, q subcomponent,
b polypeptide
Macrophage, microglia, spleen,
lymph nodes
Complement activation, classical pathway 2.1
Itgb6 Integrin b 6 Kidney, lung, skeletal muscle Cell adhesion/signaling/inflammation 3.1
Cell signaling
Dusp1 Dual specificity phosphatase 1 Macrophage, lung, dendritic cell Inactivation of MAPK activity 2
Rem1 Rad- and gem-related GTP-binding protein 1 Myoblasts Signal transduction 2
Map3k4 Mitogen-activated protein kinase kinase kinase 4 Ubiquitous Intracellular protein kinase cascade 4.8
Tprkb Tp53rk-binding protein liver, kidney, eye protein catabolic process 2.3
Ywhaq Tyrosine 3-monooxygenase/tryptophan 5-mono-
oxygenase activation protein, theta polypeptide
Embryonal stem cells, neuronal
tissue
Signal transduction 2
Regulation of expression
Crx Cone-rod homeobox-containing gene Retina Regulation of transcription 3.5
Myb Myeloblastosis oncogene Myeloid progenitor, T cell G1/S transition of mitotic cell cycle 2.2
Bcas2 Breast carcinoma amplified sequence 2 Embryonal stem cells mRNA processing 2.3
Paip1 Polyadenylate-binding protein-interacting protein 1 stem cell, pro-B cell Positive regulation of translation 7.4
Cell adhesion/morphogenesis
Vcl Vinculin Lung, mast cells Focal adhesion plaque formation 3
Cdh15 Cadherin 15 Muscle Cell adhesion 2.6
Npnt Nephronectin Lung, kidney Cell–cell adhesion mediated by integrin 2.8
Parva Parvin, a Osteoblasts, stem cells, lung Cell adhesion 2.9
Lung/respiratory tract
Bpifa1 BPI fold-containing family A, member 1 Lung, heart 17.6
Bpifb1 BPI fold-containing family B, member 1 Lung, stomach 7.3
Scgb1a1 Secretoglobin, family 1A, member 1 Lung 10.3
Scgb3a2 Secretoglobin, family 3A, member 2 Lung 3.2
Detoxification
Cyp2f2 Cytochrome P450, family 2, subfamily f,
polypeptide 2
Lung, lacrimal gland, salivary
gland, liver
Response to toxinoxidation-reduction process 2.2
Cyp2a4 Similar to cytochrome P450, family 2, subfamily a,
polypeptide 4
Lacrimal gland Oxidation-reduction process 12.8
Myeloid cell activation
Snca Synuclein, a Bone marrow, neuronal tissue Myeloid leukocyte activation 2.1
Trim10 Tripartite motif-containing 10 Bone marrow Myeloid cell haemopoiesis 4.5
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Table 1 (Continued )
Symbol Description Tissue/cell specificity Biological processa Ratiob
Ion transport
Slc4a1 Solute carrier family 4 (anion exchanger), member 1 Bone marrow Anion transport 2.2
Lrrc26 Leucine-rich repeat containing 26 Salivary gland, lacrimal gland Ion transport 2
Miscellaneous
Ap2a2 Adaptor protein complex AP-2, a 2 subunit CD4 T cell, granulocytes Endocytosis 3
Bc1 Brain cytoplasmic RNA 1 Translational repressor activity 2.7
Mus81 MUS81 endonuclease homolog (yeast) Adipose tissue, muscle DNA repair 2.1
Mccc2 Methylcrotonoyl-Coenzyme A carboxylase 2 (b) Adipose tissue, liver, kidney Coenzyme A metabolic process 2
Spa17 Sperm autoantigenic protein 17 Testis Ciliary or flagellar motility 2.1
Myl4 Myosin, light polypeptide 4 Heart, lung Muscle contraction 2.5
Agr2 Anterior gradient homolog 2 Intestine, lacrymal gland ER secreory pathway 4.2
Agr3 Anterior gradient homolog 3 Lung, testis ER secreory pathway 10
Downregulated in vM3.MR-infected wood mice
Regulation of expression
Rnpc3 RNA-binding region (RNP1, RRM) containing 3 Ubiquitous Regulation of alternative mRNA splicing, via spliceo-
some
2.5
Malat1 Metastasis-associated lung adenocarcinoma transcript
1 (non-coding RNA)
Adrenal gland Regulation of alternative mRNA splicing, via spliceo-
some
2.2
Malat1 Metastasis-associated lung adenocarcinoma transcript
1 (non-coding RNA)
Regulation of alternative mRNA splicing, via spliceo-
some
3.0
Nsa2 NSA2 ribosome biogenesis homolog B cells, mast cells and
macrophages
rRNA processing 4.3
Ddx6 DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 B cells, T cells Cytoplasmic mRNA processing body assembly 2.0
C1d C1D nuclear receptor co-repressor Myeloid, dendritic cells,
osteoblasts
Regulation of transcription 2.9
Mtf1 Metal response element-binding transcription factor 1 Lacrimal gland, testis Regulation of transcription 2.7
Ankrd1 Ankyrin repeat domain 1 (cardiac muscle) Heart Regulation of transcription 2.2
Fubp1 Far upstream element (FUSE)-binding protein 1 Embryonal stem cells, T cells, B
cells
Regulation of transcription 6.0
Nfic Nuclear factor I/C Muscle, adipose tissue Regulation of transcription 3.3
Yap1 Yes-associated protein 1 Embryonal Stem cells, placenta Regulation of transcription 2.0
Hist1h1c Histone cluster 1, H1c Pancreas, intestine, osteoblast Chromatin organization 4.0
Srp9 Signal recognition particle 9 Lacrimal gland, prostate Negative regulation of translational elongation 3.0
Ion transport
Slc39a8 Solute carrier family 39 (metal ion transporter),
member 8
Lung, uterus, cornea Zinc ion transport 2.0
Nipal2 NIPA-like domain containing 2 Salivary, lacrimal glands Magnesium ion transport 5.9
Mfsd7c Major facilitator superfamily domain containing 7C Placenta Haeme transport 2.0
Sln Sarcolipin Macrophage, thymocyte Regulation of calcium ion transport 7.3
Atp6v0b ATPase, Hþ transporting, lysosomal V0 subunit B Macrophage, microglia Proton transport 2.0
Cell signaling
Rnd3 Rho family GTPase 3 Dendritic cell, fibroblast,
osteoblast
Small GTPase-mediated signal transduction 3.0
Calm1 Calmodulin 1 Ubiquitous Response to calcium ion 7.0
Leprot Leptin receptor overlapping transcript Mast cell, macrophage,
osteoblast
Negative regulation of JAK-STAT cascade 2.0
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performed at 50 1C for 30min with 2mg RNA in a 20-ml
reaction volume containing 200 U Superscript III reverse
transcriptase (Invitrogen), 500 ng oligo(dT)15 primer
(Roche), 0.5mM dNTP mix (Promega), 5mM DTT, 40 U
RNase inhibitor (RNaseOUT; Life Technologies) in First-
Strand buffer (50mM Tris-HCl (pH 8.3), 75mM KCl, 3mM
MgCl2; Life Technologies). Afterwards, 2ml was used as
template for RT-PCR in 20 ml reaction volumes. The oligo-
deoxynucleotide primers used for PCR are provided in
Table 2. The cycling parameters were initially 95 1C for
10min, and then for each cycle: 94 1C for 10 s, 60 1C for 20 s,
and 72 1C for 60 s. The products were inserted into pCR2.1
using a TOPO-TA cloning kit (Life Technologies) according
to the manufacturer’s instructions. DNA from these cultures
was extracted by alkaline lysis and sequenced commercially
(Eurofins MWG, Germany). Six clones were sequenced
for each gene and the sequence obtained compared with
existing sequences using BLASTN.36 The sequences have been
submitted to Genbank and have accession numbers
HM008619 (Scgb1a1) and HM008620 (Bpifa1).
Table 1 (Continued )
Symbol Description Tissue/cell specificity Biological processa Ratiob
Igbp1 Immunoglobulin (CD79A)-binding protein 1 Granulocytes Negative regulation of stress-activated MAPK cascade 2.4
Camk1d Calcium/calmodulin-dependent protein kinase ID Dendritic cells, neuronal tissue Protein modification process 2.0
Immune/inflammatory response
Igk-V1 Immunoglobulin k chain variable 1 (V1) Intestine, spleen, B cell 2.4
Bcap29 B-cell receptor-associated protein 29 B cells, macrophage, testis Apoptosis/intracellular transport 3.0
Sod2 Superoxide dismutase 2, mitochondrial Macrophage, microglia Response to reactive oxygen species 5.0
Retnla Resistin like a Adipose tissue, lung Hormone activity/Inflammatory response 2.1
Tbk1 TANK-binding kinase 1 Macrophage Positive regulation of interferon-a/b 2.0
Cell adhesion/morphogenesis
Itgav Integrin a V Macrophage, osteoblast Cell adhesion/phagocytosis 4.8
Sirpa Signal-regulatory protein a Macrophage Phagocytosis 2.5
Sytl1 Synaptotagmin-like 1; similar to synaptotagmin-like 1 Salivary, lacrimal glands Exocytosis 4.7
Cyfip1 Cytoplasmic FMR1-interacting protein 1 Macrophage, microglia Cell morphogenesis 6.8
Cell cycle
Cdc123 Cell division cycle 123 Ubiquitous G1 phase of mitotic cell cycle 6.6
Commd5 COMM domain containing 5 Macrophage Cell cycle arrest 2.2
Miscellaneous
Zdhhc12 zinc finger, DHHC domain containing 12 macrophage 3.0
Ssfa2 Sperm-specific antigen 2 epidermis, mast cells,
macrophage
2.7
Ndufa2 NADH dehydrogenase (ubiquinone) 1
a subcomplex, 2
Ubiquitous Electron transport chain 2.0
Tpm3 Tropomyosin 3, g NK cells, mast cells Nervous system development 2.4
Pgk1 Phosphoglycerate kinase 1 Macrophage, skeletal muscle Glucose catabolic process 3.8
Bgn Biglycan Osteoblast, fibroblast, lung Extracellular matrix 11.7
2700089E24Rik RIKEN cDNA 2700089E24 gene Salivary gland, mammary gland 4.3
Ckap4 Cytoskeleton-associated protein 4 Osteoblast, fibroblast 2.7
Ttn Titin Heart, mammary gland,
skeletal muscle
Sarcomere organization 3.9
Mb Myoglobin Ubiquitous Oxygen transport 2.7
Acaa1a Acetyl-Coenzyme A acyltransferase 1A Liver, kidney Fatty acid metabolic process 4.2
Hsd17b7 Hydroxysteroid (17-b) dehydrogenase 7 Ovary, liver, macrophage Steroid biosynthetic process 4.8
aGene symbol, description, tissue/cell specificity, and Biological Process were annotated using DAVID (http://david.abcc.ncifcrf.gov/)56,57 and BioGPS (http://
biogps.org/).58
bRatio of the normalized signal intensities obtained after Affymetrix genechip analysis for animals infected with vM3.MR vs vM3.stop. Only genes (probe sets)
showing greater than twofold change in value and with a Po0.001 with respect to Present or Absent flags are represented.
Bolded values are transcripts that were significantly upregulated and the focus of this manuscript.
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Quantitative Reverse Transcriptase-PCR
qRT-PCR was performed as previously described12 using
total RNA purified from the lungs (see above). Each sample
was amplified in triplicate and the means from three animals
were used and expressed relative to the copy number of the
house-keeping gene 60S ribosomal protein L8 (Rpl8) cDNA.
The oligodeoxynucleotide primers used for PCR are provided
in Table 3.
Histology, IH, and In Situ Hybridization
Lung and trachea were fixed in 4% buffered paraformal-
dehyde for 24–48 h and routinely paraffin wax embedded.
Consecutive sections (3–5 mm) were either stained with
hematoxylin and eosin, used for IH or RNA in situ
hybridization (RNA-ISH) and double stains.
IH was performed using the peroxidase anti-peroxidase
method as previously described.37,38 Primary antibodies used
were rabbit anti-mSCGB1A1 (a kind gift of Barry Stripp)39
and rabbit anti-mBPIFA1 that was generated previously to
an epitope localized in the N-terminal portion of the protein
that is unique to the rodent lineage.25 The specificity of
these targets had been determined previously. Papanicolaou’s
hematoxylin or the alcian blue/periodic acid–Schiff (AB-PAS)
reaction for the demonstration of mucins were used as
counterstains for the IH.
Detection of RNA by RNA-ISH followed a previously
described protocol using digoxigenin-labeled sense and
antisense probes, which were generated by in vitro trans-
cription (digoxigenin RNA Labelling Kit (SP6/T7), Roche
Applied Science, Mannheim, Germany).12,40,41 RNA-ISH
probes were generated using IMAGE clones of mouse
Scgb1a1 (MGC:41130, IMAGE:1434396) and Bpifa1 (MGC:
62586, IMAGE:6314015) in pBluescript SK that were obtained
via the Mammalian Gene Collection.42 Control sense strand
probes were consistently found to show no reaction when
hybridized to sections of wood mouse lung.
In addition, a combination of two techniques was used in
which RNA-ISH was followed by IH.
Quantitative Histopathological Assessment
The percentage area and density of DAB staining within
airway epithelium was quantified using whole slide images
scanned and analyzed using the Chromavision automated
cellular imaging system (ACIS II) and ACIS Product version
2.4.8.0 (Clarient, Inc.) and Matroxs Imaging Library. Re-
gions of interest comprising the airway epithelium and ex-
cluding other cells were outlined and defined as trachea,
bronchus, or bronchiole. The ACIS system analyses thresh-
olds of hue, luminosity, and saturation, which were set re-
lative to the chromogen (DAB) utilized for BPIFA1 and
SCGB1A1 localization. These data provided an average
density of staining for each region of interest. The percentage
area stained was defined as the brown area (positive im-
munostaining) divided by the total brown area plus blue area
(hematoxylin; negative staining)  100. The data from each
anatomical area are presented as the mean±standard error of
the mean (s.e.m.) for each time point of infection. Statistical
significance was determined by Student’s t-test and values of
Po0.05 considered significant, calculated using Minitab v.15
(Minitab Inc.).
Transmission Electron Microscopy
Sections of lung and trachea were fixed in 4% para-
formaldehyde with 2.5% glutaraldehyde in 0.1M sodium
cacodylate buffer, and were routinely embedded in epoxy
resin. Semi-thin sections (0.5 mm) were prepared to select
areas of interest. Ultrathin (60 nm) sections were cut,
mounted on copper grids, stained with Reynold’s lead citrate,
and viewed with an H600 TEM (Hitachi).
Statistical Analysis
Data were analyzed by one-way ANOVA with Bonferroni
post-tests using the minitab v16 statistical package; P-values
were set at 95% confidence interval.
RESULTS
Transcriptional Signatures Associated with MHV-68 M3
Expression During Infection
Our earlier study revealed that M3 is critical for modulating
the host response wood mice. Thus, the efficient establish-
ment of virus latency and formation of iBALT in the lung are
dependent on M3 expression.9,15 To gain further insight into
the mechanism of M3 action, we identified genes that
were differentially expressed in the presence and absence of
M3. RNA extracted from the lungs of wood mice at day 14
p.i. with recombinant MHV-68 vM3.stop (M3-deficient) or
vM3.MR (marker-rescue expressing M3) was analyzed
using high-density microarrays. This revealed a limited
number of genes (n¼ 89) whose expression was at least two-
fold changed (Table 1). Functional annotation and grouping
of these genes was performed. Of note were the obvious
upregulation of genes encoding immunoglobulins and a
downregulation of a high proportion of macrophage-specific
genes in wood mice infected with vM3.MR as compared with
vM3.stop infection. Of particular interest, several genes
expressed in the airway epithelium encoding secreted glyco-
proteins were also upregulated in vM3.MR-infected wood
Table 2 Primers used for amplification of A. sylvaticus Scgb1a1
and Bpifa1 cDNA for cloning
Primer Gene Sequence 50-30 Product
length (bp)
SCGB1A1-f Scgb1a1 CCTCTGGCCTCTACCATGAA 351
SCGB1A1-r Scgb1a1 GACAGGGGCCTTTAGCAGTA
BPIFA1-f Bpifa1 ACTCAGACACCAAGAGAGAT 1011
BPIFA1-r Bpifa1 CGTGAGGAGAAGGAAGACAT
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mice. These included two members of the secretoglobin
family (SCGB1A1 (club cell secretory protein or uteroglobin)
and SCGB3A2 (uteroglobin-related protein 2)) and two
members of the BPI fold-containing protein family (BPIFA1
(short PLUNC1, SPLUNC1) and BPIFB1 (long PLUNC1,
LPLUNC1)). Scgb1a1 and Bpifa1 were highly differentially
expressed (10.3- and 17.6-fold, respectively; Table 1 bold
print). As it had been suggested that both these proteins were
involved in airway defense,19,21 we decided to analyze these
proteins further during MHV-68 infection.
To validate the microarray results we performed qRT-PCR.
However, to ensure accurate quantification, cDNAs corre-
sponding to Scgb1a1 and Bpifa1 were generated from RNA
extracted from wood mouse lung tissue using degenerate
primers and cloned into pCR2.1. The DNA sequence of these
clones revealed that the wood mouse Scgb1a1-coding
sequence shares 93% identity at the nucleotide level with
M. musculus Scgb1a1 and that the wood mouse Bpifa1-coding
sequence shares 94% identity at the nucleotide level with
M. musculus Bpifa1. An alignment of the predicted amino-
acid sequences of SCGB1A1 and BPIFA1 from wood mouse
and other mammalian species was made using ClustalW2.043
(Supplementary Figures E1 and E2). This revealed a high
level of conservation of these proteins between wood mouse
and house mouse. Of particular note is the conservation of
an extended N-terminal glycine/proline-rich region between
wood mouse and mouse BPIFA1 (Supplementary Figure E2)
that has previously been shown to be rodent specific.
To quantify Scgb1a1 and Bpifa1 mRNA, cohorts of wood
mice were either mock-infected, infected with vM3.MR or
with vM3.stop for either 7 or 14 days. These time points were
chosen as we have shown previously that they correspond to
the peak of productive virus replication and peak of latency
expansion (and iBALT) in the wood mice.12 RNA was then
extracted from the lung tissues and analyzed by qRT-PCR
using wood mouse-specific primers (Table 3). At day 7 p.i.,
there were no significant differences in the levels of Scgb1a1
and Bpifa1 between any of the groups of wood mice
(Figure 1). However, at day 14 p.i., the levels of both Scgb1a1
and Bpifa1 transcripts were significantly elevated (Po0.05) in
the lungs of wood mice infected with vM3.MR as compared
with both mock- and vM3.stop-infected animals. Both
transcripts were also elevated in animals infected with
vM3.stop as compared with mock-infected wood mice at this
time point, although these changes were not statistically
significant. This confirms our microarray data whereby
expression of Scgb1a1 and Bpifa1 was elevated at day 14 p.i.
in vM3.MR- as compared with vM3.stop-infected animals,
but also show that there is a greater change when vM3.MR-
infected are compared with mock-infected wood mice,
suggesting that M3 was partially responsible for elevation of
the expression of these host genes. Our previously published
results15 have shown that vM3.stop is attenuated in wood
mice, the viral load at day 14 p.i. being ca 1 log lower
in M3.stop as compared with vM3.MR-infected animals.
In addition, the chemokine and cytokine levels were shown
in our previous study to vary between the two groups so it
is equally possible that other factors are responsible for
differences in SCGB1A1 and BPIFA1 expression. However,
the modulation of SCGB1A1 and BPIFA1 expression does
suggest a role for these factors during the viral infection.
As these represented novel findings, and little is known about
the function of these proteins in the context of viral infection,
we decided to concentrate on how they behave during
MHV-68 infection.
SCGB1A1 Expression is Modulated after MHV-68
Infection
To determine any anatomical- and/or temporal-based varia-
tion in SCGB1A1 after infection, trachea and lungs from
Table 3 Oligodeoxynucleotide primers used in quantitative
RT-PCR
Primer Gene Sequence 50-30 Product
length (bp)
RPL8int-f Rpl8 ACAGAGCCGTTGTTGGTGTTGT 108
RPL8int-r Rpl8 CAGTTCCTCTTTGCCTTGTACT
bSCGB1A1-f Scgb1a1 GATCGCCATCACAATCACTGTGG 156
bSCGB1A1-r Scgb1a1 GTCTGAGCCAGGGTTGAAAGG
bBPIFA1-f Bpifa1 TGGCAGCCTGAAAATCAGCTTGC 161
bBPIFA1-r Bpifa1 TGCACCAGGGTGACATCCAAAC
Figure 1 MHV-68 modulates the transcription of Scgb1a1 and Bpifa1 in
the lungs of wood mice. RNA was extracted from the lungs of infected
wood mice at days 7 and 14 p.i. as indicated and analyzed by qRT-PCR
using primers specific for wood mouse Bpifa1 and Scgb1a1. The copy
number of mRNA was normalized to the copy number of cellular Rpl8.
Bars represent mean±s.e.m. (n¼ 3). Statistically significant differences
(one-way ANOVA with Bonferroni post-tests) between groups are
represented by square brackets above. *Po0.05.
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wood mice that were either mock-infected or infected with
MHV-68 were analyzed at day 7 and 14 p.i. (Figure 2).
Histopathological analysis of hematoxylin and eosin-
stained sections revealed a pattern of changes after infection
with MHV-68 consistent with our previous observations,
represented predominantly by mutifocal mononuclear peri-
vascular and peribronchiolar as well as multifocal granulo-
matous infiltration on day 7 p.i., and perivascular and
peribronchiolar lymphocyte-dominated infiltration with
iBALT formation at day 14 p.i. (not shown).
Expression of Scgb1a1 was detected by RNA-ISH within
mock-infected wood mice in rare epithelial cells in the
trachea, but was seen more frequently in the bronchial
epithelium. Cells in the larger proximal bronchioles stained
most frequently for Scgb1a1, with numerous cells showing
Scgb1a1 transcripts. Smaller (terminal) bronchioles showed
less frequent staining for Scgb1a1 and the alveoli were nega-
tive. After infection with MHV-68, at both days 7 and 14 p.i.
the trachea and bronchi showed a distribution of Scgb1a1
expression similar to that observed in control wood mice
Figure 2 MHV-68 modulates the expression of SCGB1A1 and BPIFA1 RNA and antigen in bronchiolar epithelial cells. Lungs were harvested from
wood mice that were either mock- or MHV-68-infected at either day 7 or day 14 p.i. as indicated. RNA specific for Scgb1a1 and Bpifa1 was detected
by RNA-ISH using specific riboprobes, visualized with BCIP/NBT (dark blue–black), and counterstained with hematoxylin. Antigen was detected by
immunohistology (IH) analysis using antibodies specific for SCGB1A1 and BPIFA1, visualized with DAB, and counterstained with hematoxylin. Scale bar
represents 50 mm.
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(not shown). However, in the bronchioles, there was a
downregulation of Scgb1a1 expression at day 7 p.i. and an
upregulation at day 14 p.i. (Figure 2, top row).
The presence of SCGB1A1 protein was determined by IH
staining, which showed that the anatomical distribution of
SCGB1A1 was similar to that of Scgb1a1 RNA and to that
previously described for M. musculus44 in both mock- and
MHV-68-infected mice at both time points p.i. (Figure 2,
second row).
To assess further the amount of epithelial SCGB1A1 pro-
tein present across the respiratory tract, we performed
quantitative analysis of the IH. At day 7 p.i., the intensity of
staining for SCGB1A1 was significantly lower in the trachea
(Po0.005) and bronchioles (Po0.05) in MHV-68-infected
mice as compared with mock-infected control mice
(Figure 3a). The percentage area of epithelium that stained
positively for SCGB1A1 was similarly significantly decreased
(Figure 3b). SCGB1A1 protein changes in the bronchi were
not significant. At day 14 p.i., there were no significant al-
terations in the intensity of staining or the percentage of
tissue stained in either the trachea or bronchi (Figure 3a and
b), but within the bronchioles (closest to the site of viral
replication) there were significant increases (Po0.005) in
both parameters in MHV-68-infected wood mice compared
with mock-infected wood mice (Figure 3).
BPIFA1 Expression is Modulated after MHV-68 Infection
Anatomical and temporal changes in Bpifa1 RNA and BPI-
FA1 protein expression following MHV-68 infection were
similarly determined in the same wood mice used for
SCGB1A1 analysis. The BPIFA1 antibody used was generated
to an epitope localized in the N-terminal portion of the
protein that is unique to the rodent lineage (Supplementary
Figure E2). This epitope shares 13/16 amino acids with the
mouse sequence used to generate the antibody.
In mock-infected wood mice, Bpifa1 RNA was most
notable in the trachea and bronchi, within the respiratory
epithelium (non-ciliated cells; Figure 2, third row) and
the submucosal glands. Within the bronchioles there were
scattered Bpifa1-positive cells. We did not detect Bpifa1
expression in the alveoli. Following infection with
MHV-68, there were similar, high levels of Bpifa1 transcrip-
tion in the trachea and bronchi, and the proximal bronch-
ioles showed an increase in transcription at day 14 p.i.
(Figure 2, third row). The smaller terminal bronchioles
were frequently negative, showing no changes from control
animals.
IH analysis demonstrated that BPIFA1 protein was
distributed in a similar pattern to the RNA, ie, within the
non-ciliated epithelium of the trachea and bronchi and
submucosal glands and to a lesser extent in the bronchiolar
epithelium in both mock- and MHV-68-infected animals
(Figure 2, bottom row).
Quantitative analysis (Figure 4) showed that although
there was no significant difference in intensity of staining or
percentage of tissue stained in the trachea and bronchi at day
7 p.i., there was a significant decrease in the intensity of
staining (Po0.005) and in the percentage area stained
(Po0.05) in the bronchioles at this time point. In contrast,
at day 14 p.i., this pattern was reversed, as increases in
BPIFA1 staining intensity was seen at all levels of the
respiratory tract in MHV-68-infected compared with mock-
infected animals (trachea Po0.05, bronchi and bronchioles
Po0.05) and a significant increase in the area stained
was seen in the bronchi and bronchioles. This increase did
not correlate well with the staining for Bpifa1 transcripts by
RNA-ISH.
Figure 3 SCGB1A1 protein levels are modulated after MHV-68 infection. Lungs were harvested from wood mice that were either mock- or MHV-68-
infected at either day 7 or day 14 p.i. as indicated. SCGB1A1 was detected by IH analysis using antibodies specific for SCGB1A1, visualized with DAB,
and counterstained with hematoxylin. The intensity of staining (a) and percentage area of epithelium stained (b) in the trachea, bronchi, and
bronchioles were assessed by image analysis. Data are for three mice per group presented as mean±s.e.m. (n¼ 3). Significant differences from
mock-infected mouse values are shown by an asterisk.
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To investigate further the apparent discrepancy between
the detection of Bpifa1 RNA and BPIFA1 protein in
bronchioles, double staining (IH and RNA-ISH) was per-
formed on the same slide. The results showed co-localization
of RNA and protein in trachea, bronchi, and proximal
bronchioles (Figure 5a), but the presence of BPIFA1 protein
without evidence of Bpifa1 RNA in the terminal bron-
chioles (Figure 5b). In addition, BPIFA1 protein was localized
predominantly intracellularly in larger airways (Figure 5a)
within what appear to be storage granules (Figure 5c). In
contrast, the strong staining observed in the terminal
bronchioles was present not only within the airway epi-
thelium but also in the airway lumen or apical surface of the
cells (Figure 5b).
Club Cells can be Multi-Functional
Club cells by definition secrete SCGB1A1.45,46 To investigate
if the same cells that produced SCGB1A1 also secreted
BPIFA1, we used a combination of RNA-ISH and IH to
determine co-localization. An RNA probe for Bpifa1 was used
followed by detection of SCGB1A1 by IH. This identified
club cells in the bronchioles that expressed both Bpifa1
transcripts and SCGB1A1 antigen (Figure 5d). To determine
if club cells also produced mucins, IH using the SCGB1A1
antibody was performed as before and the AB-PAS reaction
to highlight carbohydrates (neutral mucins: magenta, acidic
mucins: blue) was applied as counterstain. The results
(Figure 5e) identified club cells positive for SCGB1A1 that
also contained AB-PAS-positive granules in the cytoplasm,
consistent with mucus vesicles. Thus, we show for the first
time that club cells producing SCGB1A1 not only can
produce mucus after virus infection but also produce in-
creased amounts of BPIFA1.
Club Cells in the Bronchiole become Vesiculated after
Infection
As MHV-68 infection lead to an induction of mucus pro-
duction by club cells, we wished to determine if this was as-
sociated with a corresponding alteration in their
morphological phenotype. TEM was performed on lung tissue
of mock- or MHV-68-infected wood mice at day 14 p.i. The
proportion of ciliated vs non-ciliated epithelial cells was as-
sessed as was the proportion of club cells with either a com-
mon or more vesiculated morphology indicative of mucus
secretion, as previously defined.44 In mock-infected animals,
the overwhelming majority of club cells demonstrated the
typical or common morphology, including cytoplasm of
moderate electron density, organized arrays of smooth
endoplasmic reticulum, and electron-dense secretory vesicles
in the apical part of the cell (Figure 6a and c) at all levels of the
respiratory tract. In wood mice infected with MHV-68, in
addition to the common type of club cell, vesiculated club cells
were observed. These were infrequent in the trachea but in-
creased in number in the distal airways (Figure 6b and c)
making up ca 10% of bronchial and ca 25% of bronchiolar
club cells. They exhibited marked vesiculation of the apical
part or all of the cytoplasm and the vesicles contained mod-
erately electron-dense material characteristic of mucin. There
was no significant difference in the proportion of ciliated and
non-ciliated epithelial cells revealed no significant difference
after infection (Figure 6d).44
DISCUSSION
We have developed MHV-68 infection of wood mice as an
authentic system to study g-herpesvirus infection. MHV-68
encodes a chemokine-binding protein termed M3, and in the
current study, we used our wood mouse system along with a
Figure 4 BPIFA1 protein levels are modulated after MHV-68 infection. Lungs were harvested from wood mice that were either mock- or MHV-68-
infected at either day 7 or day 14 p.i. as indicated. BPIFA1 was detected by IH analysis using antibodies specific for BPIFA1, visualized with DAB, and
counterstained with hematoxylin. The intensity of staining (a) and percentage area of epithelium stained (b) in the trachea, bronchi, and bronchioles
were assessed by image analysis. Data are for three mice per group presented as mean±s.e.m. (n¼ 3). Significant differences from mock-infected
mouse values are shown by an asterisk.
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Figure 5 SCGB1A1 and BPIFA1 RNA and protein are co-expressed with mucus in club cells. (a, b) Combined IH analysis for BPIFA1 protein (visualized
with DAB, arrow) and RNA-ISH with Bpifa1-specific probes (visualized with NBT/BCIP, arrowhead) demonstrates the presence of BPIFA1 protein in the
distal terminal bronchioles (b) without evidence of Bpifa1 transcription at this site, which occurred in the proximal bronchioles (a) and upper airways in
MHV-68-infected wood mice at day 14 p.i. Hematoxylin counterstain. (c) IH analysis for BPIFA1 antigen (DAB, arrow) demonstrates granular staining in
club cells in the cytoplasm consistent with intra-vesicular storage. (d) IH analysis for SCGB1A1 protein (DAB, arrows) was used to identify club cells and
subsequent RNA-ISH with Bpifa1-specific probes demonstrated that club cells also transcribe Bpifa1 (arrowheads). Hematoxylin counterstain. (e) Club
cells identified by staining for SCGB1A1 protein (DAB, arrows) also contained AB-PAS-positive vesicles within the cytoplasm (arrowheads), consistent
with mucous vesicles, suggesting that club cells also have the potential to produce mucus.
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virus deficient in M3 expression (vM3.stop) to identify
transcriptional signatures associated with the M3 protein
during infection of the lung. Among other changes, this
identified a significant upregulation of Scgb1a1 and Bpifa1
expression that was not only associated with expression of
M3 but also with MHV-68 infection in general. We further
examined the differential temporal and spatial expression of
these two genes and their products in airways during MHV-
68 infection of wood mice. This showed that BPIFA1 can be
expressed and stored in granules within club cells along
with SCGB1A1 and that there is a decrease in expression of
both proteins in the bronchioles at day 7 p.i. consistent with
release of stored protein. At day 14 p.i., the expression of both
proteins increased. This is associated with the production of
mucus in club cells.
Global analysis indicated differential expression of 89
genes between vM3.stop and vM3.MR-infected wood mice at
day 14 p.i. (Table 1). Of note is the upregulation of a number
of genes encoding immunoglobulins in mice infected with
vM3.MR, which in likely a consequence of iBALT formation
in these animals and its absence in vM3.stop-infected wood
mice.15 It is also interesting that the expression of a high
proportion of macrophage-specific genes was downregulated
in vM3.MR-infected mice as compared with vM3.stop
infection. This suggests disruption of macrophage function
by M3 in vivo and fits well with the in vitro evidence for M3
binding to chemokines that affect macrophage function13,14
and the in vivo evidence that M3 results in lower levels of
macrophage-specific chemokines.15
The most highly differentially expressed genes at day 14 p.i.
were Scgb1a1 and Bpifa1. Differential expression was con-
firmed by qRT-PCR and in addition it was found that
expression of both genes was lower in mock-infected animals
than after either vM3.MR or vM3.stop virus infection
(Figure 1). However, at day 7 p.i., there were no significant
differences in the expression of either gene between any of the
groups. A reduction in the level of expression of both genes
in the mock control between day 7 and day 14 is likely due to
alterations in expression caused by anesthesia and adminis-
tration of PBS carrier and underlines the importance of using
this control at both time points. The potential function of the
M3 chemokine-binding protein in modulation of Scgb1a1
and Bpifa1 expression is interesting, but likely to be complex,
and made more so by the M3-deficient virus being less pa-
thogenic than vM3.MR, and hence, harboring a much higher
viral load in the lung.15 Modulation of Scgb1a1 and Bpifa1
expression after MHV-68 infection clearly suggests a role for
these factors in the host response. However, future studies
will concentrate on if or how M3 might have a role in
modulating expression of these interesting proteins.
The expression of Scgb1a1 RNA was most frequently
observed in the bronchiolar epithelium in mock-infected
wood mice (Figure 2), but was also present throughout the
respiratory epithelium, similar to that seen in M. musculus.44
At day 7 p.i. with MHV-68, there was a decrease in Scgb1a1
RNA in the bronchioles and a significant decrease in both
intensity of staining and percentage area stained for SCGB1A1
protein in the trachea and bronchioles (Figures 2 and 3). In
contrast, there was no difference in expression of Scgb1a1
mRNA detected by qRT-PCR between mock- and MHV-68-
infected wood mice in the lungs at this time point (Figure 1).
This discrepancy is probably due to the decreased RNA ex-
pression within bronchioles (as detected by RNA-ISH) being
rendered undetectable by qRT-PCR analysis in a background
of RNA extracted from whole lung tissue, including trachea
and bronchi, where there was no difference in Scgb1a1 RNA
expression. This highlights the value of RNA-ISH in our
analysis. However, at day 14 p.i., there was an increase in
Scgb1a1 expression in infected animals within the bronchiolar
epithelium (Figures 1 and 2). In line with this, there were
significant increases in SCGB1A1 protein in the bronchioles
in MHV-68-infected wood mice (Figures 2 and 3).
The precise function of SCGB1A1 is not known, although
it has been shown to inhibit phospholipase A2 and the
production of IFN-g, IL-1, and TNF-a.16 In addition,
Scgb1a1 / mice infected with respiratory syncytial virus
display an increased inflammatory response and also, increa-
sed viral titer when compared with wild-type animals.21 Mice
deficient in SCGB1A1 that are infected with adenovirus also
show a more intense inflammatory response.22 Thus, our
observations of modulation of SCGB1A1 expression after
infection with MHV-68 fit with a role in host defense and/or
immunomodulation.
In laboratory mice, BPIFA1 is found predominantly in the
upper respiratory tract and palate47 as a product of the
airway epithelium23,47,48 and the submucosal glands.48,49 In
humans, it is found predominantly in the non-ciliated cells
of the upper respiratory tract and submucosal glands.50 We
observed a similar pattern of expression in wood mice
(Figure 2). After infection, we detected Bpifa1 RNA in non-
ciliated epithelial cells in the trachea, bronchi, and proximal
bronchioles but not terminal bronchioles (Figure 5a and b).
When we analyzed BPIFA1 protein by IH, however, we found
its presence in the entire respiratory tract, although the
staining was less intense in the terminal bronchioles than in
the trachea and bronchi (Figure 2), where the staining was
mostly within granules in club cells (Figure 5c). Interestingly,
IH analysis also identified the protein cell-free within the
lumen of some terminal bronchioles (Figure 5b). Quantita-
tive analysis showed that BPIFA1 levels were decreased in
bronchioles at day 7 p.i. but increased throughout the entire
respiratory tract in response to infection at day 14 p.i.
(Figure 4). Our results show for the first time that BPIFA1 is
produced and stored in club cells. The presence of BPIFA1
protein in the terminal bronchioles in the apparent absence
of RNA is enigmatic. There is no precedence for secreted
proteins to travel from higher up in the respiratory tract to
terminal bronchioles, so BPIFA1 protein in this region could
represent limited local production and rapid secretion from
amounts of RNA that we did not detect by RNA-ISH. A
SCGB1A1 and BPIFA1 modulation by MHV-68
GH Leeming et al
12 Laboratory Investigation | Volume 00 00 2014 | www.laboratoryinvestigation.org
recent report has described a decrease in BPIFA1 in the
bronchio-alveolar lavage fluid after challenge of mice with
bacteria and influenza A virus up to 7 days p.i. and suggested
that BPIFA1 may act as a sensor of exposure to pathogens.51
The site of production of BPIFA1 was not analyzed in this
study, nor were later time points, but the results concur with
our observation of its reduced expression in bronchioles at
day 7 p.i. during acute infection. In turn, the increased levels
of BPIFA1 protein that we observed throughout the entire
respiratory tract at day 14 p.i. may indicate a distinct role in
the resolution of infection.
The cellular locations of SCGB1A1 and BPIFA1 overlap,
but are not identical. We have shown here that cells positive
for SCGB1A1 protein in bronchioles also transcribe Bpifa1
Figure 6 Transmission electron microscopic analysis of the morphology of club cells before and after infection. Transmission electron microscopy was
used to quantify the morphological type and frequency of epithelial cells in the respiratory tract of wood mice. (a) Bronchiole. In mock-infected wood
mice, the common type of club cell morphology vastly predominated with numerous electron-dense secretory vesicles in the apical part of the cell
(arrow). (b) Bronchiole. A proportion of club cells, particularly in the bronchioles of MHV-68-infected wood mice at day 14 p.i. exhibited a distinct
morphology with marked vesiculation of the apical part or all of the cytoplasm (arrows) and vesicles containing moderately electron-dense material
characteristic of mucin (arrowheads). (c) The proportion of types of club cells in the airways was determined by enumeration of cell types present in
electron micrograph images. (d) The proportion of ciliated and non-ciliated cells in the airways was determined by enumeration of cell types present in
electron micrograph images.
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(Figure 5d). Thus, we show for the first time that club cells
are able to produce BPIFA1 and also appear to retain the
protein within granules (Figure 5c). We also found the
morphology of a proportion of club cells changed in response
to infection and that the ‘vesiculated type’ of club cell44
became much more frequent in the bronchioles of infected
wood mice (Figure 6). The club cells also appeared to pro-
duce mucin following infection, as indicated by the AB-PAS
reaction (Figure 5e). Club cells have been shown to produce
mucus in response to antigen challenge,52 although other
reports dispute that they have the capacity to store mucin
and rather undergo metaplasia, becoming goblet-like cells.53
Boers et al.,54 in a survey of club cells in humans, found that
SCGB1A1 expression and a positive PAS reaction within the
same cell occurred in between 25 and 45% of goblet cells,
depending on the location within the respiratory tract. This
was defined as an ‘intermediate’ cell type with characteristics
of both goblet cells and club cells.54 Our results suggest that a
proportion of club cells may undergo differentiation toward a
goblet cell morphology, and may be in part the mechanism of
mucous metaplasia observed in response to viral infection.55
The increase in BPIFA1 expression seen here at day 14 p.i.
may also be associated with the phenotypic alteration of club
cells into mucin-secreting cells.
Like SCGB1A1, the precise function of BPIFA1 is un-
known. It has a surfactant-like effect28 and is involved in the
regulation of the amiloride-sensitive epithelial sodium
channel, ENaC.29 Infection with Mycoplasma spp. induces
Bpifa1 expression in murine airways30 and, importantly,
BPIFA1 enhances IL-8 production and bacterial clearance.30
Recent data also suggest that the protein may be implicated
in the mediation of host responses through modulation of
macrophage function.32 Thus, the modulation of BPIFA1
expression after MHV-68 infection is consistent with a
function in host defense and/or immune modulation
including, possibly, sensing of infection.51
Our data show that the quantitative modulation of two
proteins, SCGB1A1 and BPIFA1, is associated with MHV-68
infection. Although there are subtle differences, the temporal
and spatial distribution of these two molecules throughout the
respiratory tract is generally coordinated suggesting some
commonality of regulation. Both proteins are stored in gran-
ules in club cells and their decrease in expression at day 7 p.i. is
consistent with release of stored protein during the phase of
acute MHV-68 virion production and epithelial cell damage.
An increase in both proteins along with mucus and a change
in morphology of a proportion of club cells likewise suggests a
role for both proteins during the resolution of virion pro-
duction and the establishment of latency. This also highlights a
potentially important role of the club cell during virus infec-
tion in terms of secretion of factors involved in host defense.
Supplementary Information accompanies the paper on the Laboratory
Investigation website (http://www.laboratoryinvestigation.org)
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